TY - JOUR T1 - Dosimetry in Radiopharmaceutical Therapy JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 1467 LP - 1474 DO - 10.2967/jnumed.121.262305 VL - 63 IS - 10 AU - Joe O’Donoghue AU - Pat Zanzonico AU - John Humm AU - Adam Kesner Y1 - 2022/10/01 UR - http://jnm.snmjournals.org/content/63/10/1467.abstract N2 - The application of radiopharmaceutical therapy for the treatment of certain diseases is well established, and the field is expanding. New therapeutic radiopharmaceuticals have been developed in recent years, and more are in the research pipeline. Concurrently, there is growing interest in the use of internal dosimetry as a means of personalizing, and potentially optimizing, such therapy for patients. Internal dosimetry is multifaceted, and the current state of the art is discussed in this continuing education article. Topics include the context of dosimetry, internal dosimetry methods, the advantages and disadvantages of incorporating dosimetry calculations in radiopharmaceutical therapy, a description of the workflow for implementing patient-specific dosimetry, and future prospects in the field. ER -